Arenja, N., André, F., Riffel, J., Siepen, F. a. d., Hegenbart, U., Schönland, S., . . . Buß, S. J. (2019). Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis. BioMed Central.
Chicago-Zitierstil (17. Ausg.)Arenja, Nisha, Florian André, Johannes Riffel, Fabian aus dem Siepen, Ute Hegenbart, Stefan Schönland, Arnt Kristen, Hugo Katus, und Sebastian Johannes Buß. Prognostic Value of Novel Imaging Parameters Derived from Standard Cardiovascular Magnetic Resonance in High Risk Patients with Systemic Light Chain Amyloidosis. London: BioMed Central, 2019.
MLA-Zitierstil (9. Ausg.)Arenja, Nisha, et al. Prognostic Value of Novel Imaging Parameters Derived from Standard Cardiovascular Magnetic Resonance in High Risk Patients with Systemic Light Chain Amyloidosis. BioMed Central, 2019.